Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)

Patent No. EP2909232 (titled "Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)") was filed by Centre National DE LA Recherche Scientifique Cnrs on Oct 17, 2013. The application was issued on Mar 11, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREDec 11, 2020MACLEAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2909232

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP13777084A
Filing Date
Oct 17, 2013
Status
Revoked
Apr 4, 2025
Publication Date
Mar 11, 2020